Diabetes medicines spend rises by almost 20% in one year
Diabetes medications now account for 15% of all NHS England prescription spending, with costs having risen by 18% in the past year, according to NHS Business Services Authority (NHSBSA) data. The figures, published on 21 August 2025, have suggested that an estimated 3.9 million people were identified as receiving treatment with diabetes medicines in 2024/2025 […]
Publication Details
- Journal
- Pharmaceutical journal/The pharmaceutical journal
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1211/pj.2025.1.371072
- Primary Topic
- Pharmaceutical Economics and Policy
- Type
- article
- Field-Weighted Citation Impact
- 0.00